针对复发性Clostridioides difficile感染的便微生物群治疗
Jens Walter1, Fergus Shanahan2
1APC Microbiome Ireland and Department of Medicine, University College Cork, Cork, Ireland; School of Microbiology, University College Cork, Cork, Ireland.
Cell
|March 17, 2023
概括
通过恢复肠道微生物群,Rebyota是一种便微生物悬浮剂,可以预防复发的Clostridioides difficile感染. 它可能通过引入有益的微生物来发挥作用,
科学领域:
- 微生物学
- 胃肠病学
- 传染性疾病
背景情况:
- 复发性困难菌感染 (CDI) 是一个重大的临床挑战.
- 便微生物移植 (FMT) 有效地预防CDI复发.
- Rebyota提供标准化,直肠注射的便微生物悬浮剂,用于预防CDI.
研究的目的:
- 描述Rebyota,一种用于预防复发性CDI的新型便微生物悬浮液.
- 阐明Rebyota在预防CDI复发方面的可能作用机制.
主要方法:
- 作为便微生物群悬浮剂,Rebyota是通过直肠注射的.
- 该研究侧重于拟议的作用机制,而不是临床试验数据.
主要成果:
- 雷比奥塔的机制可能涉及捐赠微生物的C. difficile竞争性排除.
- 保护性肠道类型的恢复和微生物组的调节可能是导致的因素.
- 微生物代谢物和菌体活动也可能对Rebyota的疗效起作用.
结论:
- 对于预防复发性心脏病发作来说,Rebyota是一个潜在的治疗选择.
- 它的机制涉及肠道微生物组的多方面的恢复和调节.
- 进一步的研究可能会阐明各种微生物和代谢成分的确切贡献.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
246
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
246
Drugs for Treatment of Constipation-Predominant IBS
261
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
261
Drugs for Treatment of Ulcerative Colitis in IBD
202
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
202
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
221
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
221
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
184
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
184
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
381
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
381


